A Decrease in AFP Level Related to Administration of Interferon in Patients with Chronic Hepatitis C and a High Level of AFP

This publication has 19 references indexed in Scilit:

• Clinical Significance of Elevated Alpha-Fetoprotein (AFP) in Patients with Chronic Hepatitis C, but not Hepatocellular Carcinoma
  American Journal of Gastroenterology, 2004
• Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
  New England Journal of Medicine, 2002
• Activation of STAT3 by the Hepatitis C Virus Core Protein Leads to Cellular Transformation
  Journal of Experimental Medicine, 2002
• Combined intraarterial 5‐fluorouracil and subcutaneous interferon‐α therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches
  Cancer, 2002
• Effects of Long-Term Postoperative Interferon-α Therapy on Intrahepatic Recurrence after Resection of Hepatitis C Virus–Related Hepatocellular Carcinoma
  Annals of Internal Medicine, 2001
• Intravenous glycyrrhizin for the treatment of chronic hepatitis C: A double‐blind, randomized, placebo‐controlled phase I/II trial
  Journal of Gastroenterology and Hepatology, 1999
• Interferon Alfa Receptor Expression and Growth Inhibition by Interferon Alfa in Human Liver Cancer Cell Lines
  Hepatology, 1999
• Risk Factors for Hepatocellular Carcinoma among Patients with Chronic Liver Disease
  New England Journal of Medicine, 1993
• Evaluation of Five Tumor Markers (AFP, CEA, hCG, hPL and SP1) in Monitoring Therapy and Follow-up of Patients with Testicular Germ Cell Tumors
  Oncology, 1983
• Serum alpha-fetoprotein (AFP) in benign and malignant gastrointestinal diseases: Evaluation of an immunoenzymatic assay
  Clinica Chimica Acta, 1975